Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,647 Million (Small Cap)
14.00
NA
3.23%
-0.54
7.38%
1.06
Revenue and Profits:
Net Sales:
251 Million
(Quarterly Results - Mar 2025)
Net Profit:
10 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.72%
0%
8.72%
6 Months
23.74%
0%
23.74%
1 Year
21.99%
0%
21.99%
2 Years
-1.6%
0%
-1.6%
3 Years
5.26%
0%
5.26%
4 Years
-1.38%
0%
-1.38%
5 Years
35.01%
0%
35.01%
Beijing SDL Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.49%
EBIT Growth (5y)
23.43%
EBIT to Interest (avg)
39.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.54
Tax Ratio
15.26%
Dividend Payout Ratio
92.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.17%
ROE (avg)
8.40%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.06
EV to EBIT
7.58
EV to EBITDA
6.16
EV to Capital Employed
1.13
EV to Sales
0.91
PEG Ratio
1.67
Dividend Yield
3.23%
ROCE (Latest)
14.94%
ROE (Latest)
7.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY
Mar'25
Mar'24
Change(%)
Net Sales
251.40
229.40
9.59%
Operating Profit (PBDIT) excl Other Income
8.10
-6.10
232.79%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.20
-6.50
256.92%
Operating Profit Margin (Excl OI)
32.40%
-70.50%
10.29%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2025 is 9.59% vs -22.24% in Mar 2024
Consolidated Net Profit
YoY Growth in quarter ended Mar 2025 is 256.92% vs -123.05% in Mar 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,408.30
1,495.70
-5.84%
Operating Profit (PBDIT) excl Other Income
202.50
217.30
-6.81%
Interest
1.70
20.30
-91.63%
Exceptional Items
-10.40
-0.60
-1,633.33%
Consolidate Net Profit
169.60
202.70
-16.33%
Operating Profit Margin (Excl OI)
115.50%
117.80%
-0.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -5.84% vs 0.15% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -16.33% vs -28.58% in Dec 2023
About Beijing SDL Technology Co., Ltd. 
Beijing SDL Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






